Monday, February 3, 2014
The biotech industry continued
to pad its coffers in January in a rush of follow-ons that should leave many
companies well placed to ride out an eventual downturn.
Last week alone, five companies
raised $470.9 million in follow-ons to bring the month's total to $1.48
billion in 20 deals.